Literature DB >> 22924579

A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy.

N Papanas1, A J M Boulton, R A Malik, C Manes, O Schnell, V Spallone, N Tentolouris, S Tesfaye, P Valensi, D Ziegler, P Kempler.   

Abstract

A simple non-invasive indicator test (Neuropad(®)) has been developed for the assessment of sweating and, hence, cholinergic innervation in the diabetic foot. The present review summarizes current knowledge on this diagnostic test. The diagnostic ability of this test is based on a colour change from blue to pink at 10 min, with excellent reproducibility, which lends itself to patient self-examination. It has a high sensitivity (65.1-100%) and negative predictive value (63-100%), with moderate specificity (32-78.5%) and positive predictive value (23.3-93.2%) for the diagnosis of diabetic peripheral neuropathy. It also has moderate to high sensitivity (59.1-89%) and negative predictive value (64.7-91%), but low to moderate specificity (27-78%) and positive predictive value (24-48.6%) for the diagnosis of diabetic cardiac autonomic neuropathy. There are some data to suggest that Neuropad can detect early diabetic neuropathy, but this needs further evaluation. It remains to be established whether this test can predict foot ulceration and amputation, thereby contributing to the identification of high-risk patients.
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22924579     DOI: 10.1111/dme.12000

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  20 in total

1.  Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score.

Authors:  Stephan Kress; Helmut Anderten; Anja Borck; Guido Freckmann; Lutz Heinemann; Ulrike Holzmüller; Bernd Kulzer; Alexandra Portele; Oliver Schnell; Helga Varlemann; Claudia Zemmrich; Ralf Lobmann
Journal:  J Diabetes Sci Technol       Date:  2020-06-10

Review 2.  New vistas in the diagnosis of diabetic polyneuropathy.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Endocrine       Date:  2014-05-17       Impact factor: 3.633

Review 3.  Preventing and treating foot complications associated with diabetes mellitus.

Authors:  Frank L Bowling; S Tawqeer Rashid; Andrew J M Boulton
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

Review 4.  Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy.

Authors:  N Papanas; D Ziegler
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 5.  Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Rev Diabet Stud       Date:  2015-08-10

6.  The diagnostic accuracy of Neuropad for assessing large and small fibre diabetic neuropathy.

Authors:  G Ponirakis; I N Petropoulos; H Fadavi; U Alam; O Asghar; A Marshall; M Tavakoli; R A Malik
Journal:  Diabet Med       Date:  2014-07-14       Impact factor: 4.359

Review 7.  [Diabetic polyneuropathy].

Authors:  D Ziegler
Journal:  Internist (Berl)       Date:  2020-03       Impact factor: 0.743

Review 8.  The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention.

Authors:  Aaron I Vinik; Marie-Laure Nevoret; Carolina Casellini
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-11       Impact factor: 5.555

9.  Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy.

Authors:  Georgios Ponirakis; Hassan Fadavi; Ioannis N Petropoulos; Shazli Azmi; Maryam Ferdousi; Mohammad A Dabbah; Ahmad Kheyami; Uazman Alam; Omar Asghar; Andrew Marshall; Mitra Tavakoli; Ahmed Al-Ahmar; Saad Javed; Maria Jeziorska; Rayaz A Malik
Journal:  J Diabetes Res       Date:  2015-05-12       Impact factor: 4.011

10.  Determinants of microbial load in infected diabetic foot ulcers: a pilot study.

Authors:  M Demetriou; N Papanas; M Panopoulou; K Papatheodorou; E Maltezos
Journal:  Int J Endocrinol       Date:  2013-06-26       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.